SNWV
SANUWAVE Health, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.83
−2.62%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$5.05
From 52W high−86.33%
Volume58489.00
Market cap$41.55M
P/E (TTM)2.9x
P/S (TTM)0.9x
Div yield—
Key dataOct 19, 2026
Open
$5.05
From 52W high
−86.33%
Volume
58489.00
Market cap
$41.55M
ValuationView details →
P/E (Fwd)
3.8x
EV/EBITDA
2.7x
P/E (TTM)
2.9x
RSI (14)
47.1
MomentumView details →
1D Return
−2.62%
YTD Return
−83.55%
SummaryUpdated Jun 1, 2026
SANUWAVE Health, Inc. (NASDAQ:SNWV) is a medical device company founded in 2005 and headquartered in Suwanee, Georgia. The company specializes in developing and commercializing shock wave technology for regenerative medicine applications. SANUWAVE went public in 2009 and recently uplisted to NASDAQ in March 2025 after trading on lower exchanges. The company has transformed from a research-focused organization into a commercial-stage medical device manufacturer, experiencing significant revenue growth and expanding its market presence in wound care and other therapeutic applications.
Similar companies
Latest newsMore news →
SANUWAVE Health, Inc. received a Nasdaq notice dated September 23, 2026 that it no longer complies with the $35 million minimum market value of listed securities requirement under Nasdaq Listing Rule 5450(b)(2)(A), giving it until March 22, 2027 to regain compliance.24d agoSanuwave reported Q2 FY2026 financial results with revenues of $9.7 million, down 3% from $10.1 million in Q2 2025, and gross margin of 76.2% versus 78.1% in Q2 2025.74d ago